US2021047701A1PendingUtilityA1

Saccharomyces cerevisiae tci907, composition and use of saccharomyces cerevisiae tci907, and/or its metabolites

Assignee: TCI CO LTDPriority: Aug 14, 2019Filed: Aug 14, 2020Published: Feb 18, 2021
Est. expiryAug 14, 2039(~13.1 yrs left)· nominal 20-yr term from priority
C12N 1/185A61K 36/064C12R 2001/865A61K 35/747A61P 17/00A23L 33/135A61Q 19/02A61K 2800/782A61K 8/99A23V 2002/00A61Q 19/00A61K 35/66C12N 1/18A61P 3/08A61P 3/04C12R 1/865
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Saccharomyces cerevisiae TCI907 was deposited in the German Collection of Microorganisms and Cell Cultures under the accession number DSMZ33480. The Saccharomyces cerevisiae TCI907 and/or its metabolites can be used to prepare compositions that regulate blood glucose, lose weight or reduce the production of advanced glycation end products.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 .  Saccharomyces cerevisiae  TCI907, deposited in the German Collection of Microorganisms and Cell Cultures under an accession number DSMZ33480. 
     
     
         2 . A composition, comprising  Saccharomyces cerevisiae  TCI907, a metabolite of the  Saccharomyces cerevisiae  TCI907, or a combination thereof, wherein the  Saccharomyces cerevisiae  TCI907 is deposited in the German Collection of Microorganisms and Cell Cultures under an accession number DSMZ33480. 
     
     
         3 . The composition of  claim 2 , wherein the  Saccharomyces cerevisiae  TCI907 and/or the metabolite of the  Saccharomyces cerevisiae  TCI907 have/has a function of inhibiting activity of amylase. 
     
     
         4 . The composition of  claim 2 , wherein the  Saccharomyces cerevisiae  TCI907 and/or the metabolite of the  Saccharomyces cerevisiae  TCI907 have/has a function of depleting carbohydrates. 
     
     
         5 . The composition of  claim 2 , wherein the  Saccharomyces cerevisiae  TCI907 has a function of reducing production of advanced glycation end products in a host, thereby reducing an oxidation stress caused by the advanced glycation end products. 
     
     
         6 . The composition of  claim 2 , wherein the  Saccharomyces cerevisiae  TCI907 has a function of improving a basic metabolic capacity of a host. 
     
     
         7 . The composition of  claim 2 , wherein the  Saccharomyces cerevisiae  TCI907 and/or the metabolite of the  Saccharomyces cerevisiae  TCI907 have/has a function of reducing fat accumulation. 
     
     
         8 . A method for regulating blood glucose of a subject comprising administering to the subject a composition containing an effective amount of  Saccharomyces cerevisiae  TCI907 and/or a metabolite thereof, wherein the  Saccharomyces cerevisiae  TCI907 is deposited in the German Collection of Microorganisms and Cell Cultures under an accession number DSMZ33480. 
     
     
         9 . The method of  claim 8 , wherein a dosage form of the composition is in a capsule shape, and a dosage of the composition is the  Saccharomyces cerevisiae  TCI907 of 5×10 7  colony-forming unit/capsule (CFU/cap). 
     
     
         10 . A method for losing weight of a subject comprising administering to the subject a composition containing an effective amount of  Saccharomyces cerevisiae  TCI907 and/or a metabolite thereof, wherein the  Saccharomyces cerevisiae  TCI907 is deposited in the German Collection of Microorganisms and Cell Cultures under an accession number DSMZ33480. 
     
     
         11 . The method of  claim 10 , wherein a dosage form of the composition is in a capsule shape, and a dosage of the composition is the  Saccharomyces cerevisiae  TCI907 of 5×10 7  colony-forming unit/capsule (CFU/cap). 
     
     
         12 . A method for reducing production of advanced glycation end products of a subject comprising administering to the subject a composition containing an effective amount of  Saccharomyces cerevisiae  TCI907 and/or a metabolite thereof, wherein the  Saccharomyces cerevisiae  TCI907 is deposited in the German Collection of Microorganisms and Cell Cultures under an accession number DSMZ33480. 
     
     
         13 . The method of  claim 12 , wherein a dosage form of the composition is in a capsule shape, and a dosage of the composition is the  Saccharomyces cerevisiae  TCI907 of 5×10 7  colony-forming unit/capsule (CFU/cap).

Join the waitlist — get patent alerts

Track US2021047701A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.